131 related articles for article (PubMed ID: 37832865)
41. Clinical and sociodemographic risk factors associated with the development of second primary cancers among postmenopausal breast cancer survivors.
Bailey S; Ezratty C; Mhango G; Lin JJ
Breast Cancer; 2023 Mar; 30(2):215-225. PubMed ID: 36316601
[TBL] [Abstract][Full Text] [Related]
42. Vitamin D deficiency in melanoma patients is associated with worse overall survival: a retrospective cohort study.
Gracia-Darder I; Carrera C; Alamon-Reig F; Puig S; Malvehy J; Podlipnik S
Melanoma Res; 2022 Oct; 32(5):384-387. PubMed ID: 35979670
[TBL] [Abstract][Full Text] [Related]
43. Is head and neck melanoma a distinct entity? A clinical registry-based comparative study in 5702 patients with melanoma.
Hoersch B; Leiter U; Garbe C
Br J Dermatol; 2006 Oct; 155(4):771-7. PubMed ID: 16965427
[TBL] [Abstract][Full Text] [Related]
44. The Melanoma and Breast Cancer Association: An Overview of their 'Second Primary Cancers' and the Epidemiological, Genetic and Biological correlations.
Jeyakumar A; Chua TC; Lam AK; Gopalan V
Crit Rev Oncol Hematol; 2020 Aug; 152():102989. PubMed ID: 32485529
[TBL] [Abstract][Full Text] [Related]
45. A role for photoproducts of vitamin D in the etiology of cutaneous melanoma?
Braun MM; Tucker MA
Med Hypotheses; 1997 Apr; 48(4):351-4. PubMed ID: 9160291
[TBL] [Abstract][Full Text] [Related]
46. Risk of second primary cancer associated with pre-diagnostic smoking, alcohol, and obesity in women with keratinocyte carcinoma.
Park SM; Li T; Wu S; Li WQ; Qureshi AA; Stampfer M; Cho E
Cancer Epidemiol; 2017 Apr; 47():106-113. PubMed ID: 28242577
[TBL] [Abstract][Full Text] [Related]
47. 25-Hydroxyvitamin D levels and survival in advanced pancreatic cancer: findings from CALGB 80303 (Alliance).
Van Loon K; Owzar K; Jiang C; Kindler HL; Mulcahy MF; Niedzwiecki D; O'Reilly EM; Fuchs C; Innocenti F; Venook AP;
J Natl Cancer Inst; 2014 Aug; 106(8):. PubMed ID: 25099612
[TBL] [Abstract][Full Text] [Related]
48. Racial disparity in death from colorectal cancer: does vitamin D deficiency contribute?
Fiscella K; Winters P; Tancredi D; Hendren S; Franks P
Cancer; 2011 Mar; 117(5):1061-9. PubMed ID: 20945439
[TBL] [Abstract][Full Text] [Related]
49. Non melanoma skin cancer and subsequent cancer risk.
Rees JR; Zens MS; Gui J; Celaya MO; Riddle BL; Karagas MR
PLoS One; 2014; 9(6):e99674. PubMed ID: 24937304
[TBL] [Abstract][Full Text] [Related]
50. Evaluation of the usefulness of vitamin D as a predictor of mortality in patients with COVID-19.
Martínez-Rodríguez EJ; Gutiérrez-Mejía J; Ríos-Castañeda C; Rojas-Maya S; Soto-Mota A
Gac Med Mex; 2022; 158(1):31-35. PubMed ID: 35404928
[TBL] [Abstract][Full Text] [Related]
51. Serum 25-hydroxyvitamin D3 levels and vitamin D receptor variants in melanoma patients from the Mediterranean area of Barcelona.
Ogbah Z; Visa L; Badenas C; Ríos J; Puig-Butille JA; Bonifaci N; Guino E; Augé JM; Kolm I; Carrera C; Pujana MÁ; Malvehy J; Puig S
BMC Med Genet; 2013 Feb; 14():26. PubMed ID: 23413917
[TBL] [Abstract][Full Text] [Related]
52. Vitamin D deficiency is associated with mortality and adverse vascular access outcomes in patients with end-stage renal disease.
Walker JP; Hiramoto JS; Gasper WJ; Auyang P; Conte MS; Rapp JH; Lovett DH; Owens CD
J Vasc Surg; 2014 Jul; 60(1):176-83. PubMed ID: 24582700
[TBL] [Abstract][Full Text] [Related]
53. Racial and Ethnic Disparities in Survival Among People With Second Primary Cancer in the US.
Sung H; Nisotel L; Sedeta E; Islami F; Jemal A
JAMA Netw Open; 2023 Aug; 6(8):e2327429. PubMed ID: 37540510
[TBL] [Abstract][Full Text] [Related]
54. A Prospective Study to Evaluate the Possible Role of Cholecalciferol Supplementation on Autoimmunity in Hashimoto's Thyroiditis.
Bhakat B; Pal J; Das S; Charaborty SK; SircarMedical NR; Kolkata ; RGKar ; NorthBengal ; Siliguri
J Assoc Physicians India; 2023 Jan; 71(1):1. PubMed ID: 37116030
[TBL] [Abstract][Full Text] [Related]
55. Risk factors for second primary melanoma among Dutch patients with melanoma.
Schuurman MS; de Waal AC; Thijs EJM; van Rossum MM; Kiemeney LALM; Aben KKH
Br J Dermatol; 2017 Apr; 176(4):971-978. PubMed ID: 27596937
[TBL] [Abstract][Full Text] [Related]
56. The association between malignant melanoma and noncutaneous malignancies.
Wu YH; Kim GH; Wagner JD; Hood AF; Chuang TY
Int J Dermatol; 2006 May; 45(5):529-34. PubMed ID: 16700785
[TBL] [Abstract][Full Text] [Related]
57. 25-Hydroxyvitamin D in Patients With Melanoma and Factors Associated With Inadequate Levels.
Hernández-Ostiz S; Pérez-Ramada MD; Ortiz B; Requena C; Ribas G; Aznar E; Nagore E
Actas Dermosifiliogr; 2016 Nov; 107(9):758-764. PubMed ID: 27418183
[TBL] [Abstract][Full Text] [Related]
58. Second primary cancers in patients with stage III non-small cell lung cancer successfully treated with chemo-radiotherapy.
Kawaguchi T; Matsumura A; Iuchi K; Ishikawa S; Maeda H; Fukai S; Komatsu H; Kawahara M
Jpn J Clin Oncol; 2006 Jan; 36(1):7-11. PubMed ID: 16368713
[TBL] [Abstract][Full Text] [Related]
59. Second primary melanomas: Increased risk and decreased time to presentation in patients exposed to tanning beds.
Li Y; Kulkarni M; Trinkaus K; Cornelius LA
J Am Acad Dermatol; 2018 Dec; 79(6):1101-1108. PubMed ID: 30009864
[TBL] [Abstract][Full Text] [Related]
60. Prognostic significance of BRAF and NRAS mutations in melanoma: a German study from routine care.
Heppt MV; Siepmann T; Engel J; Schubert-Fritschle G; Eckel R; Mirlach L; Kirchner T; Jung A; Gesierich A; Ruzicka T; Flaig MJ; Berking C
BMC Cancer; 2017 Aug; 17(1):536. PubMed ID: 28797232
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
